临床药师参与肾内科联合门诊服务工作的实践

doi:10.11669/cpj.2020.23.011

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1073 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨临床药师参与肾内科联合门诊服务工作的模式和作用。方法由肾内科医师、临床药师、营养师和护士4方组成治疗团队,为慢性肾脏病(chronic kidney disease,CKD)患者提供全方位的治疗管理。统计2018年1月至2019年7月在肾内科联合门诊就诊的CKD患者基本信息、疾病诊断、依从性评估和药物重整(medication reconciliation,MR)信息等,采用欧洲药学监护网络基金会(PCNE)分类V9.0版对患者存在的药物相关问题(drug related problems,DRPs)进行评估及干预并进行统计分析。结果本研究最终共纳入62例患者88例次就诊资料。其中CKD 2期3例(4.84%)、CKD 3期43例(69.35%)、CKD 4期11例(17.74%)、CKD 5期5例(8.06%)。合并高血压最多,共41例(66.13%)、合并高尿酸血症30例(48.39%)、合并高脂血症14例(22.58%)、合并糖尿病10例(16.13%)、合并贫血9例(14.52%)。每位患者平均服用药物(6.11±2.44)种(1~13种),服药≥5种的患者有47例(75.81%)。药师共发现DRP 93个,危害性分级中C级共29个(31.18%),D级27个(29.03%),A级25个(26.88%),E级11个(11.83%),B级1个(1.08%)。经干预后DRPs全部被解决,86.67%的复诊患者经干预后依从性能达到8分。结论临床药师参与联合门诊可以提高CKD患者的依从性,减少DRPs,保障患者用药安全。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	郁文刘
	刘星星
	陆若琳
	刘雪
	沈蕾
	杭永付

关键词 ：药物重整, 慢性肾脏病, 联合门诊, 临床药师

Abstract：OBJECTIVE To investigate the mode of multidisciplinary outpatient service in the department of nephrology participated by the clinical pharmacist. METHODS The treatment team consist of clinical pharmacist, clinician, nurse and nutritionist in the department of nephrology provides comprehensive treatment for patients with chronic kidney disease (CKD). Clinical pharmacist filled the CKD patients records who visited the outpatient department of nephrology from January 2018 to July 2019 including basic information, disease diagnosis, drug compliance evaluation and medication reconciliation. The PCNE classification (Version 9.00) was used to assess and intervene in the CKD patients drug related problems (DRPs) and statistical analysis of results. RESULTS According to the exclusion criteria, 88 cases and 62 patients were included in this study. 3 patients (4.84%) had stage 2 CKD, 43 patients (69.35%) had stage 3 CKD, 11 patients (17.74%) had stage 4 CKD, 5 patients (8.06%) had stage 5 CKD. 41 patients (66.13%) had hypertension, 30 patients (48.39%) had hyperuricemia, 14 patients (22.58%) had hyperlipidemia, 10 patients (16.13%) had diabetes mellitus, 9 patients (14.52%) had anemia. The average number of drugs used per patient was (6.11±2.44) species (1-13 species) and 47 patients (75.81%) took more than five species drugs. Ninty-three medication-related problems were found, distribution of harmed levels as follows: 29 problems (31.18%) were level C, 27 problems (29.03%) were level D, 25 problems (26.88%) were level A, 11 problems (11.83%) were level E, only one problem (1.08%) was level B. All of them were fully implemented by intervention, compliance score of 86.67% of subsequent visit patients were attached 8. CONCLUSION Through the intervention of clinical pharmacist to the patients with CKD, the compliance of patients can be improved, and DRPs can be reduced to ensure the efficacy and safety of drugs.

Key words： medication reconciliation chronic kidney disease multidisciplinary team clinical pharmacist

收稿日期: 2020-06-24

PACS:

R969.3

基金资助:国家临床重点专科(临床药学)建设项目资助; 江苏省药学会-恒瑞医院药学基金资助(H202032)

通讯作者: * 杭永付,男,硕士,副主任药师研究方向:临床药学 Tel:(0512)67973021 E-mail:hangyongfu1986@163.com

作者简介: 郁文刘,男,主管药师研究方向:医院药学

引用本文:

郁文刘, 刘星星, 陆若琳, 刘雪, 沈蕾, 杭永付. 临床药师参与肾内科联合门诊服务工作的实践[J]. 中国药学杂志, 2020, 55(23): 1969-1973. YU Wen-liu, LIU Xing-xing, LU Ruo-lin, LIU Xue, SHEN Lei, HANG Yong-fu. Practice of Multidisciplinary Outpatient Service in the Department of Nephrology Participated by the Clinical Pharmacist. Chinese Pharmaceutical Journal, 2020, 55(23): 1969-1973.

链接本文:

http://journal11.magtechjournal.com/Jwk_zgyxzz/CN/10.11669/cpj.2020.23.011 或 http://journal11.magtechjournal.com/Jwk_zgyxzz/CN/Y2020/V55/I23/1969

[1]	LIU X Q, CHEN Y. Research progress of nutritional management for patients with chronic renal disease[J]. Nur Integr Tradit Chin West Med(中西医结合护理), 2019,5(5):229-232.
[2]	YANG J, LIU Y, ZHANG M, et al. Exploration of entry points of traditional Chinese clinical pharmacists participating in multi-disciplinary team[J]. China Pharm(中国药师),2018,21(10):1783-1786.
[3]	HO C P, LEE T J F. The reliability and validity of the Chinese version of the eight-item Morisky medication adherence scale[J]. Value in Health, 2014, 17(7): A730.
[4]	FOUNDATION, PCNE. PCNE Classification for drug related problems V9.0. [EB/OL]. [2019-07-30]. https://www.pcne.org/upload/files/334_PCNE_classification_V9.0.pdf.
[5]	MEDICATION SAFETY PANEL IN CHINA CORE GROUP OF INTERNATIONAL NET WORK FOR THE RATIONAL USE OF DRUGS(INRUD), CHINESE PHARMACO1OGICAL SOCIETY PROFESSIONAL COMMITTEE OF DRUG INDUCED-DISEASES, CHINESE PHARMACEUTICAL ASSOCIATION PROFESSIONAL COMMITTEE OF HOSPITAL PHARMACY, et al. Expert consensus on medication error management in China[J]. Adverse Drug React J(药物不良反应杂志),2014,16(6):321-326.
[6]	NATIONAL COORDINATING COUNCIL FOR MEDICATION ERROR REPORTING AND PREVENTION. About Medication Errors[EB/OL]. [2020-06-01]. http://www.nccmerp.org/aboutMedError.html.
[7]	HAO R,HANG Y F, LIU X X, et al. Development of medication reconciliation model for chronic kidney disease in our hospital[J]. Chin Pharm J(中国药学杂志),2020,55(5):408-413.
[8]	WANG H X, ZHU X T, XIE C, et al. Primary medication reconciliation service provided by clinical pharmacist for chronic kidney disease in our hospital[J]. Chin Pharm J(中国药学杂志), 2018, 53(24):2148-2151.
[9]	ZHU X T, HANG Y F. Clinical pharmacists' pharmaceutical care and practice in the department of nephrology[J]. Chin J Clin Pharmacol Ther(中国临床药理学与治疗学),2018,23(10):1174-1178.
[10]	WANG H X, HANG Y F. Pharmaceutical services in the department of nephrology: examples and experiences[J]. Cent South Pharm(中南药学),2019,17(4):607-609.